MEI Pharma's Chief Financial Officer was just granted 200,000 options

Brian G. Drazba, MEI Pharma's Chief Financial Officer, just received 200,000 options from the company. The strike price of the options received was $2.95, and these expire on July 01, 2031. Drazba now owns at least 200,000 options on the company.

Some additional info was provided as follows:


One-quarter of such options shall vest on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
All of such options are presently exercisable.
One-quarter of such options vested on July 6, 2018 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 6, 2018.
One-quarter of such options vested on June 22, 2019 and the remaining thre e-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.
One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever MEI Pharma makes a similar move, sign up!

Auto Refresh

Feedback